Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2017-06-19
2018-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kinect based Rapid Movement Therapy
Kinect based Rapid Movement Therapy (RMT) training requires participants to move their limbs very rapidly to reach-to-grasp or step towards a virtual target appear suddenly on a screen, which is designed to their range of motion as well as response speed.
Balance training
Improvement of balance ability in stroke patients
Conventional balance training
Conventional balance training involves some slow and low-impact muscle strengthening and mobilizing exercises.
Balance training
Improvement of balance ability in stroke patients
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Balance training
Improvement of balance ability in stroke patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. have unilateral paresis,
3. are 50 years of age or older,
4. able to stand without aid for at least 15min,
5. have moderate level of motor impairment in the affective upper limb, i.e. 15≤ Fugl-Meyer Assessment for upper-extremity(FMA-UE) ≤ 45,
6. have some level of deficit in balance control, i.e. Berg Balance Scale(BBS)\< 52/56,
7. have a minimum Snellen visual acuity of 20/40 with/without spectacles,
8. have a minimum Mini-Mental-Status-Examination score of 22/30, and
9. have to be able to follow the training procedures.
Exclusion Criteria
2. have other neurological conditions in addition to stroke (e.g. Parkinson's disease),
3. have unstable cardiovascular disease (e.g. history of heart disease, or poorly controlled hypertension, i.e. blood pressure \>160mmHg/100mmHg), or
4. have other serious diseases or conditions (e.g. osteoporosis, recent joint replacement surgery, amputation) that preclude them from participating in the study.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raymond KY Tong
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raymond Kai-yu Tong, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Biomedical Engineering, CUHK
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Biomedical Engineering, The Chinese University of Hong Kong
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Junata M, Cheng KC, Man HS, Lai CW, Soo YO, Tong RK. Kinect-based rapid movement training to improve balance recovery for stroke fall prevention: a randomized controlled trial. J Neuroeng Rehabil. 2021 Oct 11;18(1):150. doi: 10.1186/s12984-021-00922-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12131911
Identifier Type: -
Identifier Source: org_study_id